Australian & New Zealand Childrens Haematology/Oncology Group


A multicentre study of SARS-CoV-2 infection in children with cancer, immunodeficiency or following stem cell transplant

Infectious Diseases Physician, Dr Gabrielle Haeusler, is leading a multi-centre surveillance study of COVID-19 in children with cancer, are otherwise immunocompromised or following stem cell transplant in collaboration with the Murdoch Children’s Research Institute (MCRI) and the Australian National Centre for Infections in Cancer (NCIC).

This study aims to evaluate the signs, symptoms and outcomes of COVID-19 in these children and also to identify risk factors for severe illness. Information will be collected on children in Australia and New Zealand with a number of international sites also taking part to ensure that accurate and reliable information of COVID-19 is gathered as quickly and efficiently as possible.

ANZCHOG is assisting in the facilitation of this study and has also convened a clinical reference group to discuss the evolving COVID-19 pandemic impact including clinical presentation, treatments and outcomes of any confirmed SARS-CoV-2 oncology cases in Australian and New Zealand.

Other related COVID-19 news:

  • COVID-19 guidance for children and young people undergoing cancer treatment: Click here